SG11201706819RA - Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease - Google Patents

Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease

Info

Publication number
SG11201706819RA
SG11201706819RA SG11201706819RA SG11201706819RA SG11201706819RA SG 11201706819R A SG11201706819R A SG 11201706819RA SG 11201706819R A SG11201706819R A SG 11201706819RA SG 11201706819R A SG11201706819R A SG 11201706819RA SG 11201706819R A SG11201706819R A SG 11201706819RA
Authority
SG
Singapore
Prior art keywords
prophylaxis
treatment
synthetic peptide
dry eye
eye disease
Prior art date
Application number
SG11201706819RA
Other languages
English (en)
Inventor
Tsung-Chuan Ho
Yeou-Ping Tsao
Original Assignee
Tsung-Chuan Ho
Yeou-Ping Tsao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsung-Chuan Ho, Yeou-Ping Tsao filed Critical Tsung-Chuan Ho
Publication of SG11201706819RA publication Critical patent/SG11201706819RA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SG11201706819RA 2015-02-25 2015-02-25 Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease SG11201706819RA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2015/073257 WO2016134498A1 (en) 2015-02-25 2015-02-25 Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease

Publications (1)

Publication Number Publication Date
SG11201706819RA true SG11201706819RA (en) 2017-09-28

Family

ID=56787800

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201706819RA SG11201706819RA (en) 2015-02-25 2015-02-25 Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease

Country Status (11)

Country Link
US (1) US10307456B2 (zh)
EP (1) EP3262060B1 (zh)
JP (1) JP6503085B2 (zh)
KR (1) KR102023827B1 (zh)
CN (1) CN107428805B (zh)
AU (1) AU2015384099B2 (zh)
CA (1) CA2977562C (zh)
ES (1) ES2772772T3 (zh)
NZ (1) NZ734845A (zh)
SG (1) SG11201706819RA (zh)
WO (1) WO2016134498A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10463710B2 (en) * 2015-04-27 2019-11-05 Mackay Memorial Hospital Short synthetic peptide for the treatment and/or prophylaxis of autoimmune and inflammatory disorders
CN108785251B (zh) * 2018-01-23 2020-11-24 盛元医药广州有限公司 一种眼用药物组合物及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3191038B2 (ja) * 1996-06-26 2001-07-23 輝夫 西田 眼科用医薬組成物
US7834146B2 (en) * 2000-05-08 2010-11-16 Monsanto Technology Llc Recombinant polypeptides associated with plants
TWI305778B (en) * 2001-12-03 2009-02-01 Nishida Teruo Peptides of an expressing unit for igf-i minimal activity and their pharmaceutical use
US7381707B2 (en) * 2005-06-30 2008-06-03 Johnson & Johnson Consumer Companies, Inc. Treatment of dry eye
US9096689B2 (en) * 2007-11-07 2015-08-04 Northwestern University Methods and compositions for inhibiting angiogenesis
CN102100693A (zh) * 2009-12-16 2011-06-22 沈阳兴齐制药有限公司 一种含有肌肽的人工泪液及其制备方法
CN101745098A (zh) * 2010-01-26 2010-06-23 暨南大学 神经多肽pacap38在制备眼部疾病的治疗、损伤修复或再生药物中的应用
CN101947307B (zh) * 2010-08-19 2012-08-15 中山大学中山眼科中心 人胎盘肽在制备治疗干眼症等眼表疾病药物中的应用
JP2015500213A (ja) * 2011-11-30 2015-01-05 ザイジェン インフラメーション リミテッド 眼乾燥症候群を処置するためのｊｎｋシグナル伝達経路の細胞透過性ペプチド阻害剤の使用
US10463710B2 (en) * 2015-04-27 2019-11-05 Mackay Memorial Hospital Short synthetic peptide for the treatment and/or prophylaxis of autoimmune and inflammatory disorders

Also Published As

Publication number Publication date
WO2016134498A1 (en) 2016-09-01
KR20170126468A (ko) 2017-11-17
NZ734845A (en) 2018-08-31
CN107428805A (zh) 2017-12-01
US10307456B2 (en) 2019-06-04
CA2977562A1 (en) 2016-09-01
EP3262060A4 (en) 2018-09-05
AU2015384099A1 (en) 2017-09-14
ES2772772T3 (es) 2020-07-08
CA2977562C (en) 2019-12-03
AU2015384099B2 (en) 2018-04-05
JP2018508514A (ja) 2018-03-29
EP3262060B1 (en) 2019-12-25
JP6503085B2 (ja) 2019-04-17
US20180339010A1 (en) 2018-11-29
KR102023827B1 (ko) 2019-09-23
CN107428805B (zh) 2021-01-08
EP3262060A1 (en) 2018-01-03

Similar Documents

Publication Publication Date Title
HK1251257A1 (zh) 用於醫治疾病的外泌體的用途
AU201810677S (en) Skin treatment article
AU201714140S (en) Skin treatment article
AU201714143S (en) Skin treatment article
AU201810686S (en) Skin treatment article
IL253872A0 (en) Unnatural semaphorins 3 and their medicinal use
IL254142B (en) Tredifitant for use in the treatment of a disease or medical condition that responds to Tredifitent
AU201810683S (en) Skin treatment article
AU201810685S (en) Skin treatment article
AU201714141S (en) Skin treatment article
AU201810689S (en) Skin treatment article
PL3277280T3 (pl) Izomiosmina do zastosowania w leczeniu chorób autoimmunologicznych
ZA201704726B (en) Peptides and their use in the treatment of skin
EP3463344A4 (en) TREATMENT OF DRY EYE WITH PARASYMPATHIC AND ANTISYMPATHIC AGENTS
AU201810687S (en) Skin treatment article
RS64703B1 (sr) Jedinjenja indolinona i njihova upotreba u lečenju fibroznih bolesti
IL281585B (en) Selenogalactoside compounds for the prevention and treatment of galectin-related diseases and their use
HK1243719A1 (zh) 用以治療血管新生相關疾病和/或症狀的短合成肽
HK1257585A1 (zh) 預防和治療皮膚纖維化的藥物及其用途
GB201504387D0 (en) Materials and methods for the treatment of vascular disease
GB201522329D0 (en) Use of adjuvants for the prevention and/or treatment of autoimmune diseases
SG11201706819RA (en) Use of short synthetic peptide for the treatment and/or prophylaxis of dry eye disease
HK1252359A1 (zh) 用於治療疼痛的曲唑酮和加巴噴丁的組合
AU201810676S (en) Skin treatment article
SG11201703624PA (en) Compounds for the diagnosis or treatment of disorders associated with protein or peptide oligomers